Insmed (INSM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...

NASDAQ INSM opened at $79.60 on Tuesday. The business’s 50 day moving average price is $73.15 and its 200-day moving average price is $73.16. Insmed has a fifty-two week low of $21.92 and a ...

Insmed Incorporated has a twelve month low of $21.92 and a twelve month high of $82.04. The company has a market cap of $14.19 billion, a price-to-earnings ratio of -14.29 and a beta of 1.11 ...

Insmed Incorporated (NASDAQ: INSM) has announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for brensocatib, a potential treatment for ...

Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. The FDA accepts and grants ...

After hours: 14 February at 19:47:31 GMT-5 ...